IMMUNITYBIO INC (IBRX) Institutional Ownership and Insiders Activity
IMMUNITYBIO INC (IBRX) is widely held by institutional investors, with 393 firms reporting positions valued at approximately $1.90B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $341.01M in IBRX holdings in its latest filing.
Recent insider activity includes 3 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
393
Total Reported Value
$1.90B
Largest Holder
Blackrock, Inc.
Largest Position
$341.01M
Insider Transactions (90d)
3
Latest Filing Quarter
Q3 2026
New Institutional Positions
60
Funds Exiting Positions
58
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$341.01M
- State Street Corp$199.14M
- Vanguard Portfolio Management Llc$183.04M
- Vanguard Capital Management Llc$177.52M
- D. E. Shaw & Co., Inc.$101.12M
Related IBRX Institutional Insights:
- IBRX 13F Institutional Holders
- IBRX Superinvestors
- IBRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- IBRX Insider Trading & SEC Form 4 Activity
- IBRX Articles
- Top Institutional Investor Stock Rankings